← FDA Drug Approvals (Drugs@FDA)

DAUNORUBICIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 1998-06-23

Drug application

FDA Application #

ANDA064212

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAUNORUBICIN HYDROCHLORIDE

Generic name

Daunorubicin Hydrochloride

Active ingredients

DAUNORUBICIN HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

1998-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown